Phenominer Database Results (60 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine norepinephrine excretion rate cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine norepinephrine amount not specified 0 days 7 4800.0 pmol/4h 328.83 870.0 high-performance liquid chromatography 0.0 0 hplc urine norepinephrine excretion rate 68656 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine norepinephrine excretion rate guanethidine (50 mg/kg/d) (for 21 days) then room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine norepinephrine amount not specified 0 days 0 4120.0 pmol/4h 550.0 high-performance liquid chromatography 0.0 0 hplc absolute change in urine norepinephrine excretion rate 68669 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in systolic blood pressure guanethidine (50 mg/kg/d) (for 21 days) then room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 5 serial mean 36.0 mmHg 2.24 5.0 radiotelemetry 16200.0 0 10 s every 5 min 68677 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart weight to body weight ratio cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart mass not specified 112 days 10 3.18 g/kg 0.07 0.22 post excision weight measurement 0.0 0 68697 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both kidneys wet weight cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. kidney mass not specified 112 days 10 3.32 g 0.07 0.23 post excision weight measurement 0.0 0 68700 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 35.0 mmHg 3.0 7.35 vascular indwelling catheter method 0.0 0 84538 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate air-jet exposure (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 105.0 beats/min 12.0 29.39 vascular indwelling catheter method 0.0 0 84559 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in plasma norepinephrine level room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. blood norepinephrine amount not specified 0 days 5 7.14 pmol/l 1.19 2.66 high-performance liquid chromatography 0.0 0 difference in plasma norepinephrine between baseline and 4 degrees 68671 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart rate control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 326.0 beats/min 12.0 29.39 vascular indwelling catheter method 0.0 0 84560 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm mean arterial blood pressure control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 107.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 69084 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in diastolic blood pressure room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 4 serial mean 38.0 mmHg 3.5 7.0 radiotelemetry 16200.0 0 10 s every 5 min 68678 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate guanethidine (50 mg/kg/d) (for 21 days) then room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart pumping trait not specified 84 days-112 days 5 serial mean 179.0 beats/min 6.26 14.0 radiotelemetry 16200.0 0 10 s every 5 min 68687 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart pumping trait not specified 84 days-112 days 6 serial mean 122.0 beats/min 12.66 31.0 radiotelemetry 16200.0 0 10 s every 5 min 68688 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm systolic blood pressure control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 112 days 10 148.0 mmHg 1.77 5.6 tail cuff plethysmography 0.0 0 10 s every 5 min 68690 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart weight to body weight ratio control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart mass not specified 112 days 10 3.03 g/kg 0.06 0.18 post excision weight measurement 0.0 0 68695 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm stimulated renal sympathetic nerve activity to basal renal sympathetic nerve activity ratio air-jet exposure (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. kidney sympathetic nerve activity male 98 days 6 216.0 % 51.0 124.92 implanted wire electrode recording method 0.0 0 percent change rsna 84540 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 50.0 mmHg 3.0 7.35 vascular indwelling catheter method 0.0 0 84572 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart rate control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 329.0 beats/min 13.0 31.84 vascular indwelling catheter method 0.0 0 84561 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 -5.0 beats/min 7.0 17.15 vascular indwelling catheter method 0.0 0 84564 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine vanillylmandelic acid excretion rate sodium chloride solution (for 21 days) then room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine vanillylmandelic acid amount not specified 0 days 0 3120.0 pmol/4h 200.0 high-performance liquid chromatography 0.0 0 hplc absolute change in vanillylmandelic acid excretion rate 68668 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) then hexamethonium (40 mg/kg) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 -48.0 mmHg 6.0 14.7 vascular indwelling catheter method 0.0 0 69090 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 4.0 beats/min 12.0 29.39 vascular indwelling catheter method 0.0 0 84565 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm cell membrane potential control condition Iigaya K, et al., Hypertension. 2008 Dec 1. action potential trait not specified 0 days-4 days 8 -49.3 mV 1.06 3.0 whole-cell patch clamp technique 600 0 irregularly firing neurons 65898 634
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine norepinephrine excretion rate room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine norepinephrine amount not specified 0 days 7 3790.0 pmol/4h 415.76 1100.0 high-performance liquid chromatography 0.0 0 hplc absolute change in urine norepinephrine excretion rate 68659 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine vanillylmandelic acid excretion rate room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine vanillylmandelic acid amount not specified 0 days 7 1540.0 pmol/4h 188.98 500.0 high-performance liquid chromatography 0.0 0 hplc absolute change in vanillylmandelic acid excretion rate 68665 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine vanillylmandelic acid excretion rate guanethidine (50 mg/kg/d) (for 21 days) then room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine vanillylmandelic acid amount not specified 0 days 0 2020.0 pmol/4h 400.0 high-performance liquid chromatography 0.0 0 hplc absolute change in vanillylmandelic acid excretion rate 68667 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine norepinephrine excretion rate sodium chloride solution (for 21 days) then room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine norepinephrine amount not specified 0 days 0 4890.0 pmol/4h 640.0 high-performance liquid chromatography 0.0 0 absolute change in urine norepinephrine excretion rate 68670 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in diastolic blood pressure guanethidine (50 mg/kg/d) (for 21 days) then room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 5 serial mean 32.0 mmHg 1.79 4.0 radiotelemetry 16200.0 0 10 s every 5 min 68680 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in systolic blood pressure room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 6 serial mean 25.0 mmHg 1.63 4.0 radiotelemetry 16200.0 0 10 s every 5 min 68681 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in heart rate room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart pumping trait not specified 84 days-112 days 4 serial mean 213.0 beats/min 12.5 25.0 radiotelemetry 16200.0 0 10 s every 5 min 68685 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart wet weight control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart mass not specified 112 days 10 1.19 g 0.03 0.09 post excision weight measurement 0.0 0 68694 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both kidneys wet weight control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. kidney mass not specified 112 days 10 3.02 g 0.06 0.18 post excision weight measurement 0.0 0 68698 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both kidneys wet weight to body weight ratio cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. kidney mass not specified 112 days 10 8.17 g/kg 0.11 0.34 post excision weight measurement 0.0 0 68701 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both adrenal glands weight to body weight ratio control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. adrenal gland mass not specified 112 days 10 16.0 mg/100g 0.63 2.0 post excision weight measurement 0.0 0 68703 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both adrenal glands wet weight cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. adrenal gland mass not specified 112 days 10 65.0 mg 2.21 7.0 post excision weight measurement 0.0 0 68704 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm percent change in mean arterial blood pressure air-jet exposure (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 33.0 % 3.0 7.35 vascular indwelling catheter method 0.0 0 84543 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) then phenylephrine (3 ug) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 56.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 84573 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 -2.0 mmHg 3.0 7.35 vascular indwelling catheter method 0.0 0 84554 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 36.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 84557 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm urine vanillylmandelic acid excretion rate cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. urine vanillylmandelic acid amount not specified 0 days 7 2200.0 pmol/4h 117.17 310.0 high-performance liquid chromatography 0.0 0 hplc urine vanillylmandelic acid exretion rate 68662 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm systolic blood pressure cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 112 days 10 157.0 mmHg 1.39 4.4 tail cuff plethysmography 0.0 0 10 s every 5 min 68691 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm body weight cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. body mass not specified 112 days 10 406.0 g 5.06 16.0 body weighing method 0.0 0 68693 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart wet weight cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. heart mass not specified 112 days 10 1.29 g 0.03 0.09 post excision weight measurement 0.0 0 68696 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in urine norepinephrine level cold ambient air exposure (4 degrees C) (for 6 hours) Xiao B, et al., J Hypertens. 2010 Nov 8. urine norepinephrine amount male 84 days 16 69.67 nmol/h high-performance liquid chromatography 0.0 0 nmol/6h 84591 990
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure candesartan (1 ug) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 -1.0 mmHg 4.0 9.8 vascular indwelling catheter method 0.0 0 84569 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) then vehicle control condition (2 ul) (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 -1.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 84555 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm mean arterial blood pressure control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 105.0 mmHg 4.0 9.8 vascular indwelling catheter method 0.0 0 84548 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure vehicle control condition (2 ul) (for 0 hours) then air-jet exposure (for 0 hours) then angiotensin II (20 ng) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 32.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 84568 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm cell membrane potential control condition Iigaya K, et al., Hypertension. 2008 Dec 1. action potential trait not specified 0 days-4 days 7 -46.4 mV 0.87 2.3 whole-cell patch clamp technique 600 0 regularly firing neurons 65894 634
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm heart rate control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. heart pumping trait male 98 days 6 321.0 beats/min 11.0 26.94 vascular indwelling catheter method 0.0 0 69087 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in systolic blood pressure room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 4 serial mean 44.0 mmHg 3.5 7.0 radiotelemetry 16200.0 0 10 s every 5 min 68675 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in diastolic blood pressure room temperature (for 0.5 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. arterial blood pressure trait not specified 84 days-112 days 6 serial mean 23.0 mmHg 1.63 4.0 radiotelemetry 16200.0 0 10 s every 5 min 68683 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm body weight control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. body mass not specified 112 days 10 393.0 g 5.66 17.9 body weighing method 0.0 0 68692 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both kidneys wet weight to body weight ratio control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. kidney mass not specified 112 days 10 7.69 g/kg 0.11 0.35 post excision weight measurement 0.0 0 68699 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both adrenal glands wet weight control condition Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. adrenal gland mass not specified 112 days 10 64.0 mg 5.38 17.0 post excision weight measurement 0.0 0 68702 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm both adrenal glands weight to body weight ratio cold ambient air exposure (4 degrees C) (for 90 days) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. adrenal gland mass not specified 112 days 10 16.0 mg/100g 0.63 2.0 post excision weight measurement 0.0 0 68705 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in mean arterial blood pressure air-jet exposure (for 0 hours) then candesartan (1 ug) (for 0 hours) Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 -10.0 mmHg 1.0 2.45 vascular indwelling catheter method 0.0 0 85199 1120
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm absolute change in plasma epinephrine level room temperature (for 4 hours) then cold ambient air exposure (4 degrees C) (for 4 hours) Cui ZH, et al., J Hypertens 2004 Nov;22(11):2103-9. blood epinephrine amount not specified 0 days 5 1.63 pmol/l 0.54 1.21 high-performance liquid chromatography 0.0 0 hplc difference in plasma epinephrine between base and 4 degrees 68673 971
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm systolic blood pressure control condition Xiao B, et al., J Hypertens. 2010 Nov 8. arterial blood pressure trait male 84 days 16 serial mean 125.0 mmHg tail cuff plethysmography 0.0 0 avg of 5 measurements 68741 990
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm mean arterial blood pressure control condition Yamazato M, et al., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R709-14. Epub 2005 Oct 20. arterial blood pressure trait male 98 days 6 103.0 mmHg 2.0 4.9 vascular indwelling catheter method 0.0 0 84551 1120